Clinical trial design in studies of corticosteroids for bacterial infections.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D001623:Betamethasone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D012189:Retrospective Studies; D012772:Shock, Septic / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality
D005938:Glucocorticoids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone